Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Transmission of SARs-CoV-2

Providing a rapid summary and evaluation of relevant data on the transmission of SARS-CoV-2, reporting important policy implications and highlighting areas of urgently needed research. 

Our multidisciplinary team has considerable expertise in evidence synthesis and the evaluation of acute respiratory infections. Carl Heneghan and Tom Jefferson lead the research and have worked together for over a decade having been authors of the Tamiflu reviews. Both are Clinical Editors for the Cochrane Acute Respiratory Infections Group.

Transmission of SARS-CoV-2

We publish updates with recommendations for policy, and a series of hypotheses to be tested by further work. Our conclusions and expected outcomes are below the byline of each review.

The transmission areas include airborne, contact and droplet, orofecal, vertical, fomite and asymptomatic and presymptomatic transmission.

SARS-CoV-2 and the role of airborne transmission: systematic review

Heneghan C; Spencer EA; Brassey J; Plüddemann A; Onakpoya I; Evans D;  Conly JM; Jefferson T. [version 1] F1000Research 2021, 52091. 

Conclusion: SARS-CoV-2 RNA is detected intermittently in the air in various settings. Standardized guidelines for conducting and reporting research on airborne transmission are needed. The lack of recoverable viral culture samples of SARS-CoV-2 prevents firm conclusions over airborne transmission.

Read the research

SARS-CoV-2 and the role of orofecal transmission: systematic review

Heneghan C; Spencer EA; Brassey J; Plüddemann A; Onakpoya I; Evans D;  Conly JM; Jefferson T. [version 1] F1000Research 2021, 51592 

Conclusions: Varied observational and mechanistic evidence suggests SARS-CoV-2 can infect and be shed from the human gastrointestinal tract, including some limited data demonstrating viral culture in fecal samples. Future studies should test this hypothesis rigorously to allow the development of appropriate public health measures.

Read the research

SARS-CoV-2 and the role of fomite transmission: systematic review

Onakpoya I; Heneghan C; Spencer EA; Brassey J; Plüddemann A; Evans D;  Conly JM; Jefferson T. [version 3] F1000Research 2021

Conclusion: The majority of studies report the identification of SARS-CoV-2 RNA on inanimate surfaces; however, the lack of positive viral cultures creates uncertainty about fomites as a mode of transmission.  The late timing of sample collection with respect to the illness onset and the variability in reported cycle thresholds and the relatively high values precludes drawing any firm conclusions. Heterogeneity in study designs and methodology prevents comparisons of findings across studies. Standardized guidelines for conducting and reporting research on fomite transmission is warranted.

Read the research

SARS-CoV-2 and the role of close contact in transmission: systematic review

Onakpoya I; Heneghan C; Spencer EA; Brassey J; Plüddemann A; Evans D;  Conly JM; Jefferson T. [version 1] F1000Research 2021

Conclusion: The evidence from published studies demonstrates that SARS-CoV-2 can be transmitted via close contact settings. The risk of transmission is greater in household contacts. There was wide variation in methodology. Standardized guidelines for reporting transmission in close contact settings should be developed to improve the quality reporting.

Read the research

SARS-CoV-2 and the role of vertical transmission from infected pregnant women to their fetuses: systematic review

Annette Plüddemann, Elizabeth A. Spencer, Carl J. Heneghan, Jon Brassey, Igho J.Onakpoya, Elena Cecilia Rosca, David H. Evans, John M. Conly, Tom Jefferson.

Conclusion: The results of these studies indicate that vertical transmission is possible, but is not frequent, and factors that influence when vertical transmission occurs are unknown. Further studies using standardised methods to establish viral infection are needed to establish vertical transmission rates and to assess clinical and other conditions affecting transmission.

Read the research

Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review (Version 1)

EC Rosca, C Heneghan, EA Spencer, J Brassey, A Plüddemann, IJ Onakpoya, DH Evans, JM Conly, T Jefferson.

Conclusion: Evidence suggests that SARS-CoV-2 can be transmitted during aircraft travel, but the published data do not permit any conclusive assessment of the likelihood and extent. Furthermore, the quality of evidence from most published studies is low. The variation in study design and methodology restricts the comparison of findings across studies. Standardized guidelines for conducting and reporting future studies of transmission on aircrafts should be developed.

Read the research

The evidence on transmission dynamics of COVID-19 from pre- and asymptomatic cases: protocol for a systematic review (Version 2)

T Jefferson, A Plüddemann, EA Spencer, J Brassey, EC Rosca, I Onakpoya, DH Evans, JM Conly, C Heneghan. 

Expected results: We intend to present the evidence in three distinct packages: study description, methodological quality assessment and data extracted. We intend on summarising the evidence and drawing conclusions as to the quality of the evidence.

Read the research

Our SYSTEMATIC REVIEWS

Impact on healthcare policy

Reference WHO registration No 2020/1077093.

The World Health Organisation funded reviews were the first phase of our project. Its objective is to undertake a series of living systematic searches and appraisal of evidence on SARS-CoV-2 modes of transmission and its related updates are informing WHO guidance and scientific documents. CH, AP and ES also receive funding support from the NIHR SPCR Evidence Synthesis Working Group project 390.

The WHO updates interim guidance (12 July 2021) on infection prevention and control (IPC) during health care when coronavirus disease (‎COVID-19)‎ is suspected or confirmed, and cites CEBM work on airborne, finite and close contact transmission as well as non pharmaceutical interventions.

Intended for health workers, including managers and IPC teams at facility, national and district/provincial levels, this guidance summarizes evidence on infection prevention and control strategies and measures associated with the care for suspected or confirmed cases of COVID-19 in health facilities. 

Updated interim guidance, July 2021

Viral cultures for COVID-19

Context

Complete live viruses are necessary for transmission, not the fragments identified by PCR. Prospective routine testing of reference and culture specimens and their relationship to symptoms, signs and patient co-factors should be used to define the reliability of PCR for assessing infectious potential. Those with a high cycle threshold are unlikely to have infectious potential.

Read the research: Viral cultures for COVID-19 infectious potential assessment – a systematic review.

What did we do?

We systematically reviewed the evidence from studies relating SARS-CoV-2 culture with the results of RT-PCR and other variables which may influence the interpretation of the test, such as time from symptom onset

PCR testing cannot distinguish between the shedding of live virus or of viral fragments with no infectious potential. Although viral culture is difficult, time-consuming and requires specialised facilities it potentially represents the best indicator of infection and infectious potential.  

Dissemination

21st Aug: It’s a mistake to think all positive Covid tests are the same Carl Heneghan, Tom Jefferson

14th Sep: What does a case of COVID-19 really mean? Carl Heneghan, Tom Jefferson

7th Sep: Covid-19 and the end of clinical medicine as we know it   Carl Heneghan, Tom Jefferson

Additional authors

John Conly, Professor of Medicine, Department of Medicine (Infectious Diseases), Cumming School of Medicine, University of Calgary and Alberta Health Services

David Evans, Professor, Department of Medical Microbiology & Immunology Chair

Elena Cecilia Rosca, Associate Professor, Department of Neurology, Victor Babes University of Medicine and Pharmacy of Timisoara

 

Viral cultures for COVID-19 infectivity assessment – a systematic review

Journal article

Jefferson T. et al, (2020)

Viral cultures for COVID-19 infectious potential assessment - a systematic review.

Journal article

Jefferson T. et al, (2020), Clin Infect Dis

Project team